About this trial
Patients born with heart defects often undergo surgical procedures on a heart lung machine. With improvements in medical and surgical management, their survival has significantly improved, but their brain insult has not been paid much attention. This study is to determine the relationship between specific proteins in the blood and brain injury in patients less than 18-year-old undergoing heart surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
less than 18 years old
undergoing cardiac surgery with cardiopulmonary bypass at Boston Children's Hospital
Disqualifiers
undergoing an emergent procedure and do not have more than 1 hour ahead of time to review the consent
patient in a moribund condition American Society of Anesthesiology (ASA 5)
patient with a hematological and/or oncological disease
Jehovah witnesses
Trial population
Patients less than 18 years old undergoing a cardiac surgical procedure at Boston Children's Hospital with cardiopulmonary bypass.
Trial design
Cohort
Prospective
Treatments tested in this trial
Collecting discarded blood samples
Other interventionDiscarded blood samples will be collected from routine clinical labs collected before and after surgery.
Treatment groups
Trial outcomes
Primary outcomes
Characterization of postoperative neurological impairment
Understand the correlation between measured proinflammatory cytokines and several proteins that are highly expressed in brain cells with postoperative neurological status.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: